Apidra SoloStar Units/ml solution for injection in a pre-filled pen – Patient The Patient Information Leaflet (PIL) is the leaflet included in the pack with a. Apidra SoloStar Units/ml solution for injection in a pre-filled pen . SoloStar, the Instructions for use included in the Package leaflet must be read carefully. APIDRA [insulin glulisine injection (rDNA origin)] is a recombinant . package insert, and the pump manufacturer’s manual (see DOSAGE AND.

Author: Shakagor Fell
Country: Tajikistan
Language: English (Spanish)
Genre: Video
Published (Last): 7 December 2008
Pages: 254
PDF File Size: 17.70 Mb
ePub File Size: 4.72 Mb
ISBN: 125-3-21132-144-8
Downloads: 53549
Price: Free* [*Free Regsitration Required]
Uploader: Menos

Travel Before travelling consult your doctor. Side effects where the frequency cannot be estimated from the available data Eye a;idra A marked change improvement or worsening in your blood sugar control can disturb your vision temporarily.

If a patient with diabetes ingests alcohol, they should be counselled to to avoid ingestion of alcohol on an empty stomach, which increases risk for low blood sugar.

If necessary, more frequent blood sugar testing can help to identify mild hypoglycaemic episodes that may otherwise be overlooked. Some medicines cause changes in the blood sugar level decrease, increase or both depending on the situation.

Remove and discard the needle Always remove the needle after each injection and store SoloStar without a needle attached. In this case, either you can inject what is remaining in the pen and complete your dose with a new SoloStar or use a new SoloStar for your full dose.

If you have any further indert on the use of this medicine, ask your doctor, pharmacist or nurse. Monitor for loss of glycemic control when pseudoephedrine, phenylephrine, and other sympathomimetics are inserr to patients taking antidiabetic agents. According to OBRA, the use of antidiabetic medications should include monitoring e. Due to cost, safety, and efficacy concerns, it may be prudent to avoid intravenous administration until more information is available.

Do not shake or mix it before use. By continuing to browse the site you are agreeing to our policy on the use of cookies. See the box at the end of this leaflet pacage further information. Rare reported side effect may affect up to apdira in 1, people Skin changes at the injection site lipodystrophy If you inject your insulin too often at the same skin site, fatty tissue under the skin at this site may either shrink or thicken.


Active ingredient insulin glulisine. Since clonidine inhibits the release of catecholamines, clonidine may hide symptoms of hypoglycemia such as tremor, tachycardia, and blood pressure changes. Patients treated with pasireotide may experience either hypoglycemia or hyperglycemia. Hypoglycemia, sometimes resulting in coma, can occur.

In general, insulin requirements decline during the first trimester and increase during the second and inserrt trimesters, insret then decline significantly after delivery. Because blood glucose may be lowered by the use of chromium, patients who are on antidiabetic agents may need dose adjustments. Discontinue the quinolone if a hypoglycemic reaction occurs and initiate appropriate therapy immediately. Major Avoid use of macimorelin in patients receiving exogenous insulin therapy.

Optimizing glycemic control before conception and during pregnancy appears to improve fetal outcome; this should include the avoidance of episodes of hypoglycemia ineert the toxic effects of maternal hypoglycemia on the fetus have been well-documented.

Moderate Patients receiving antidiabetic agents should use dietary supplements of Garlic, Allium sativum with caution. Pioglitazone should apodra discontinued if any deterioration in cardiac status occurs. Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Roll the vial of the NPH insulin gently between the palms of your hands to mix and warm the insulin. Warning symptoms of hyperglycaemia Thirst, increased need to urinate, tiredness, dry skin, reddening of the face, loss of appetite, low blood insegt, fast heart beat and glucose and ketone bodies in urine.

PDR Search

Do not push the injection button while turning, as insulin will come out. In addition, healthcare providers are advised to discontinue insulin therapy and observe a sufficient washout period before administering macimorelin.


Warnings and precautions Apidra in a pre-filled pen is only suitable for injecting just under the skin see also section 3. Administer by subcutaneous injection or intravenously only. This ensures that you get an accurate dose by: If you have type 1 diabetes insulin dependent diabetes mellitusdo inserh stop your insulin and continue to get enough carbohydrates. Dilute insulin glulisine with Sodium Chloride injection to a final concentration of 0. Moderate Hypoglycemia, including symptomatic episodes, has been noted in post-marketing reports with linezolid in patients with diabetes mellitus receiving therapy with antidiabetic agents, such as insulin and oral hypoglycemic agents.

If human insulin vials are stored under refrigeration while in use and are used beyond 30 days, the stability of these vials may be affected by a number of factors; such factors include the number of injections per day, volume of insulin remaining in the vial, exposure to light, agitation, and technique used for dose preparation. To email a medicine you must sign up and log in. What should you do if you experience hypoglycaemia? Treatment must be individualized. Acetaminophen; Chlorpheniramine; Dextromethorphan; Pseudoephedrine: Minor, local sensitivity characterized by redness, swelling, or itching at the site of injection does not usually contraindicate therapy.

Fast-Acting, Mealtime Insulin | Apidra® (insulin glulisine [rDNA origin] injection)

Speak to a doctor immediately if you are not able to control the hypoglycaemia or if it recurs. Do not use this SoloStar if the insulin is pakage, coloured or has particles. Check your blood sugar frequently.

In these clinical studies, an increased incidence of heart failure and other cardiovascular adverse events was seen in patients receiving combination rosiglitazone and insulin therapy compared to insulin monotherapy; the incidence of new onset or exacerbated heart failure was 0.